JOHN M. LEONARD - 05 Jan 2026 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
President and CEO, Director
Signature
James Basta, attorney-in-fact
Issuer symbol
NTLA
Transactions as of
05 Jan 2026
Net transactions value
-$314,485
Form type
4
Filing time
07 Jan 2026, 16:05:54 UTC
Previous filing
12 Dec 2025
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LEONARD JOHN M President and CEO, Director C/O INTELLIA THERAPEUTICS, INC., 40 ERIE STREET; SUITE 130, CAMBRIDGE James Basta, attorney-in-fact 07 Jan 2026 0001563584

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Sale $314,485 -34,146 -3.3% $9.21 1,013,339 05 Jan 2026 Direct F1
holding NTLA Common Stock 58,415 05 Jan 2026 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.
F2 Shares held by the John M. Leonard 2015 Irrevocable Trust.